scholarly journals Nicolau Syndrome After Glatiramer Acetate Injection in Close Proximity to Administration of SARS-CoV-2 mRNA Vaccine

2021 ◽  
Vol 9 (1) ◽  
pp. e1112
Author(s):  
Michael Yu Sy ◽  
Erin Fromm ◽  
Linda Doan ◽  
Nathan Rojek ◽  
Alexander Ulrich Brandt
BMC Neurology ◽  
2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Chiara Zecca ◽  
Carlo Mainetti ◽  
Roland Blum ◽  
Claudio Gobbi

2013 ◽  
Vol 28 (7) ◽  
pp. 448-449
Author(s):  
A. Pulido Pérez ◽  
V. Parra Blanco ◽  
R. Suárez Fernández

2015 ◽  
Vol 145 (12) ◽  
pp. e41 ◽  
Author(s):  
Alejandro Lobato-Berezo ◽  
Marcela Martínez-Pérez ◽  
Adrián Imbernón-Moya ◽  
Miguel Ángel Gallego-Valdés

2021 ◽  
Vol 53 (6) ◽  
pp. 489
Author(s):  
Gulsen Akoglu ◽  
Pelin Esme ◽  
Irfan Gahramanov ◽  
Egemen Akıncıoglu

Author(s):  
Caner Demircan ◽  
Neslihan Akdogan ◽  
Leyla Elmas

Nicolau syndrome, also known as embolia cutis medicamentosa, is a rare complication of injectable drugs. Patients present with pain at injection site, followed by swelling, erythema, purple, hemorrhagic patches and lastly ulcer formation. A variety of intramuscular agents have been implicated as responsible. We report a case of a 26-year-old woman with a history of a purple lesion on her thigh who was diagnosed with Nicolau syndrome due to subcutaneous administration of glatiramer acetate. The patient was followed up with topical mupirocin. On follow-up, although the patient stated that she continued using glatiramer acetate, no new lesions appeared and the existing lesion continued to shrink. Nicolau syndrome seems to have an unpredictable and unavoidable course. This case suggests that physicians should have a high index of suspicion for the presence of Nicolau syndrome in patients presenting with necrotic or ulcerative lesions with a history of using injectable drugs.


2011 ◽  
Vol 102 (9) ◽  
pp. 742-744
Author(s):  
C. Martínez-Morán ◽  
P. Espinosa-Lara ◽  
L. Nájera ◽  
A. Romero-Maté ◽  
S. Córdoba ◽  
...  

2017 ◽  
Vol 19 (3) ◽  
pp. 148-150 ◽  
Author(s):  
Dorlan J. Kimbrough ◽  
Scott D. Newsome

We report two cases of Nicolau syndrome (embolia cutis medicamentosa), a rare complication of injectable medications, both associated with the administration of 20 mg of subcutaneous glatiramer acetate. Both patients required surgical debridement and were subsequently treated conservatively without additional complications. Patient 1 opted to discontinue disease-modifying therapy. Patient 2 continued glatiramer acetate therapy without complications by using other injection sites. These cases highlight the need for prompt investigation of new unusual skin lesions in patients receiving injectable multiple sclerosis treatments (regardless of length of treatment and previous minor cosmetic concerns) and illustrate the clinical distinction between Nicolau syndrome and drug-induced skin necrosis.


2016 ◽  
Vol 43 (11) ◽  
pp. 1056-1061 ◽  
Author(s):  
Sarah E. Mott ◽  
Zachary G. Peña ◽  
Rebecca I. Spain ◽  
Kevin P. White ◽  
Benjamin D. Ehst

Author(s):  
John L. Beggs ◽  
John D. Waggener ◽  
Wanda Miller

Microtubules (MT) are versatile organelles participating in a wide variety of biological activity. MT involvement in the movement and transport of cytoplasmic components has been well documented. In the course of our study on trauma-induced vasogenic edema in the spinal cord we have concluded that endothelial vesicles contribute to the edema process. Using horseradish peroxidase as a vascular tracer, labeled endothelial vesicles were present in all situations expected if a vesicular transport mechanism was in operation. Frequently,labeled vesicles coalesced to form channels that appeared to traverse the endothelium. The presence of MT in close proximity to labeled vesicles sugg ested that MT may play a role in vesicular activity.


Sign in / Sign up

Export Citation Format

Share Document